Clinical Trial Update: A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for INCAGN01876 in advanced or metastatic solid tumors; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Malignancies

Drugs mentioned

• INCAGN01876

Snippet

Sponsor: Incyte Biosciences International Sàrl | Conditions: Advanced Malignancies, Metastatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-26